-
公开(公告)号:US11919972B2
公开(公告)日:2024-03-05
申请号:US16673657
申请日:2019-11-04
Applicant: REGENERON PHARMACEUTICALS, INC.
Inventor: Anders Eliasen
CPC classification number: C07K7/06 , A61K49/0002 , A61K49/14 , A61K51/08 , C12N15/1072 , G01N33/68
Abstract: Disclosed are peptides having non-canonical amino acids. These peptides are useful, for example, as protein binding agents. Libraries of such peptides can be used, for example to screen and select protein binding agents. The broader chemical space of the disclosed peptides can provide peptide with different, improved, more specific, and/or pharmaceutically compatible peptides and protein binding agents. In some forms, the peptides can have the following structure (I):
including stereoisomers, pharmaceutically acceptable salts and prodrugs thereof, wherein R, R1, L1, L2, G, M, Y1 Y2 and SEQ are as defined herein. Methods associated with preparation and use of such peptides, as well as pharmaceutical compositions comprising such peptides, are also disclosed.-
公开(公告)号:US11739443B2
公开(公告)日:2023-08-29
申请号:US17531618
申请日:2021-11-19
Applicant: Becton, Dickinson and Company
Inventor: Cynthia Sakofsky , Katherine Lazaruk , Margaret Nakamoto , Devon Joseph Jensen
CPC classification number: C40B30/04 , C12N15/1065 , C12N15/1072 , C40B40/10 , C40B50/06
Abstract: Disclosed herein include systems, methods, compositions, and kits for determining the expression of highly expressed proteins and lowly expressed proteins. In some embodiments, primers allowing generation of separate libraries for abundant AbSeq protein profiling oligonucleotides and scarce AbSeq protein profiling oligonucleotides are provided.
-
公开(公告)号:US11702763B2
公开(公告)日:2023-07-18
申请号:US16650899
申请日:2019-03-23
Inventor: Daisuke Umeno , Yuki Kimura , Kyohei Ouchi , Shigeko Kawai
CPC classification number: C40B30/04 , C12N15/1072 , C12N15/1086 , C12N15/62 , C12N15/63 , C12N15/70 , C12N15/63
Abstract: [Problem] Provided are a production method for a multi-input/multi-output-type genetic switch or a transcription factor, and a multi-input/multi-output-type genetic switch or a transcription factor. [Solving Means] The inventors of the present invention have completed a production method for a multi-input/multi-output-type genetic switch or a transcription factor, essentially including the steps of “fusing two or more transcription factor genes to each other” and “introducing mutations into the fusion-type transcription factor gene,” and have further succeeded in obtaining a multi-input/multi-output-type genetic switch or a transcription factor by the method.
-
公开(公告)号:US09850483B2
公开(公告)日:2017-12-26
申请号:US13811065
申请日:2011-07-19
Applicant: Michael F. Clarke , Stephen R. Quake , Piero D. Dalerba , Huiping Liu , Anne A. Leyrat , Tomer Kalisky , Maximilian Diehn , Michael Rothenberg , Jianbin Wang , Neethan Lobo
Inventor: Michael F. Clarke , Stephen R. Quake , Piero D. Dalerba , Huiping Liu , Anne A. Leyrat , Tomer Kalisky , Maximilian Diehn , Michael Rothenberg , Jianbin Wang , Neethan Lobo
CPC classification number: C12N15/1072 , C12Q1/6809 , C12Q1/6886 , C12Q2600/106 , C12Q2600/158
Abstract: Methods are provided for diagnosis and prognosis of disease by analyzing expression of a set of genes obtained from single cell analysis. Classification allows optimization of treatment, and determination of whether on whether to proceed with a specific therapy, and how to optimize dose, choice of treatment, and the like. Single cell analysis also provides for the identification and development of therapies which target mutations and/or pathways in disease-state cells.
-
公开(公告)号:US20170268047A1
公开(公告)日:2017-09-21
申请号:US15460489
申请日:2017-03-16
Applicant: Norgen Biotek Corp.
Inventor: Yousef Haj-Ahmad
CPC classification number: C12Q1/6811 , C12N15/1006 , C12N15/1072 , C12Q1/6806 , C12Q2521/501 , C12Q2525/191 , C12Q2535/122
Abstract: Disclosed are methods and kits for isolating nucleic acids having a size above a desired cut-off size from a nucleic acid containing sample. The method comprises combining the sample with a binding buffer, alcohol and silicon carbide to provide a binding mixture. Nucleic acids having a size above the desired cut-off size are selectively bound to the silicon carbide. The cut-off size for selective binding to the silicon carbide is determined by the alcohol concentration of the binding mixture. The bound nucleic acids are separated from the remaining sample. The bound nucleic acids are optionally washed and then eluted from the silicon carbide. The kit comprises a buffer binding to be diluted with alcohol to provide an alcohol concentration of about 1 to about 50% (v/v), a wash solution, an elution solution, silicon carbide and instructions for adjusting the alcohol concentration to selectively bind nucleic acids having a size above the desired cut-off size.
-
公开(公告)号:US20170267998A1
公开(公告)日:2017-09-21
申请号:US15532452
申请日:2015-12-03
Applicant: AxioMx, Inc.
Inventor: Michael WEINER
IPC: C12N15/10
CPC classification number: C12N15/1072 , C12N15/1031 , C40B50/14 , C12Q2563/179
Abstract: The present invention is directed to compositions and methods for producing one or more polynucleotides from smaller oligonucleotide segments within an emulsion. In methods of the present invention, a support having one or more capture oligo-nucleotides is contacted with two or more corresponding tile oligonucleotides. Upon hybridization of the tile oligonucleotides to the capture oligonucleotides, a capture complex is formed. This capture complex is emulsified, optionally with reaction reagents or other additives. The emulsion is then incubated at a temperature regimen sufficient for an adjoining extension reaction to occur, such that a polynucleotide may be formed from the tile oligonucleotides that hybridized to a particular support. A particular advantage of this method is that many different polynucleotides may be produced in parallel with surprising efficiency.
-
7.
公开(公告)号:US20170175109A1
公开(公告)日:2017-06-22
申请号:US15451035
申请日:2017-03-06
Applicant: Illumina, Inc.
Inventor: John R. Stuelpnagel , David L. Barker , Jorge Velarde, Jr. , Steven M. Barnard , Michael Graige
CPC classification number: C12N15/1072 , C12Q1/6837 , C12Q2565/515
Abstract: The invention provides a method of selecting a representational sample of nucleic acid sequences from a complex mixture. The method includes: (a) contacting a complex mixture of nucleic acids under conditions sufficient for hybridization with a population of capture probes complementary to one or more nucleic acids comprising a predetermined portion of the sequence collectively present in the complex mixture to form hybridization complexes of the one or more nucleic acids with the population of probes, the population of capture probes being attached to a solid support, and (b) removing unhybridized nucleic acids to select a representational sample of nucleic acids having a complexity of less than 10% but more than 0.001% of the complex mixture, wherein the representational sample comprises a nucleic acid copy having a proportion of each sequence in the copy relative to all other sequences in the copy substantially the same as the proportions of the sequences in the predetermined portion of one or more nucleic acids within the complex mixture. A method of selecting a representational sample of genomic sequences from a complete genome also is provided. The invention further provides a nucleic acid population that includes a representational sample having a complexity of less than 10% but more than 0.001% of a complex mixture, the representational sample comprising a nucleic acid copy having a proportion of each sequence in the copy relative to all other sequences in the copy substantially the same as the proportions of sequences in a predetermined portion of a sequence collectively present in one or more nucleic acids within the complex mixture.
-
公开(公告)号:US20170145492A1
公开(公告)日:2017-05-25
申请号:US15353595
申请日:2016-11-16
Applicant: Pacific Biosciences of California, Inc.
Inventor: Thang Tat Pham , Yu-Chih Tsai , Jonas Korlach , Tyson A. Clark , Stephen Turner
CPC classification number: C12Q1/6855 , C12N15/1072 , C12P19/34
Abstract: Methods are provided for reducing the complexity of a population of nucleic acids prior to performing an analysis of the nucleic acids, e.g., sequence analysis. The methods result in a subset of the initial population enriched for a target region, which is typically located within one or more target fragments. The methods are particularly useful for analyzing populations having a high degree of complexity, e.g., chromosomal-derived DNA, whole genomic DNA, or mRNA populations.
-
公开(公告)号:US09650628B2
公开(公告)日:2017-05-16
申请号:US13750768
申请日:2013-01-25
Applicant: NuGEN Technologies, Inc.
Inventor: Doug Amorese , Chris Armour , Nurith Kurn
CPC classification number: C12N15/1068 , C12N15/1072 , C12N15/66 , C12Q2525/191
Abstract: The present invention provides methods, compositions and kits for targeted nucleic acid sequence enrichment in a nucleic acid sample and for high efficiency nucleic acid library generation for next generation sequencing (NGS). Specifically, the methods, compositions and kits provided herein are useful for the production and capture of amplification-ready, target-specific and strand-specific regions of interest from nucleic acid samples containing complex DNA.
-
公开(公告)号:US20160333417A1
公开(公告)日:2016-11-17
申请号:US15071656
申请日:2016-03-16
Applicant: Guardant Health, Inc.
Inventor: AmirAli Talasaz
IPC: C12Q1/68
CPC classification number: C12Q1/6886 , C12N15/1072 , C12Q1/6869 , C12Q1/6883 , C12Q2600/118 , C12Q2600/156 , G16B30/00
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
-
-
-
-
-
-
-
-